Quick Takeaways
- Robert E. Waltermire has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,995,798.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Robert E. Waltermire
- Location
- West Conshohocken, PA
- Summary
- The estimated net worth of Robert E. Waltermire is at least $1,995,798 dollars as of 07 Mar 2025. Robert E. Waltermire is the Senior VP, Chief Pharma Dev. of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $2M.
- Signature
- /s/ Mardi Dier, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robert E. Waltermire and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: MADRIGAL PHARMACEUTICALS, INC. ($1,995,798).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Robert E. Waltermire
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Senior VP, Chief Pharma Dev. | $1,995,798 | 05 Mar 2025 |
Insider Transactions Reported by Robert E. Waltermire:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.